These emerging treatments, Semaglutide , represent a significant advancement in managing metabolic dysfunction and conceivably associated disorders. These drugs are classified as GLP-1 hormone stimulators, meaning they function to replicate the endogenous read more GLP-1 hormone , boosting glucose release and lowering hunger . Although Retatrutide